COL10A1 expression distinguishes a subset of cancer-associated fibroblasts present in the stroma of high-risk basal cell carcinoma
View abstract on PubMed
Summary
This summary is machine-generated.COL10A1 is identified as a key marker for high-risk basal cell carcinoma (BCC) subtypes, particularly sclerosing/infiltrative and basosquamous types. This finding offers potential for new prognostic biomarkers and targeted treatments for skin cancer.
Area Of Science
- Dermatology
- Oncology
- Molecular Biology
Background
- Basal cell carcinoma (BCC) is the most common human malignancy, with varying recurrence risks and aggressiveness among subtypes.
- The biological basis for BCC subtype differences is poorly understood, particularly the role of the tumor microenvironment and cancer-associated fibroblasts (CAFs).
Purpose Of The Study
- To investigate and characterize the stromal microenvironment of different basal cell carcinoma (BCC) subtypes.
- To focus on identifying specific cancer-associated fibroblast (CAF) populations and their role in BCC progression.
Main Methods
- Laser capture microdissection (LCM) followed by RNA sequencing (RNA-Seq) was employed to analyze stromal gene expression in 15 BCC samples across five pure subtypes.
- Healthy skin served as a control, and findings were validated using immunohistochemistry (IHC) and two independent single-cell RNA-Seq (scRNA-Seq) datasets.
Main Results
- Distinct gene expression signatures were observed in the stroma of different BCC subtypes, with nodular and micronodular being most similar, and superficial and sclerosing being most different.
- COL10A1 was found to be overexpressed in the stroma of high-risk sclerosing/infiltrative and basosquamous BCC subtypes, confirmed by IHC.
- scRNA-Seq analysis linked COL10A1 expression to CAFs in the stroma of infiltrative BCC, associated with extracellular matrix remodeling.
Conclusions
- COL10A1 serves as a significant marker for high-risk BCC subtypes, specifically sclerosing/infiltrative and basosquamous.
- A distinct CAF population expressing COL10A1 is associated with infiltrative BCC stroma, suggesting its role in tumor progression.
- COL10A1 presents potential as a novel prognostic biomarker for BCC, paving the way for tailored therapeutic strategies.
Related Concept Videos
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...

